Hummingbird Bioscience, HMBD-001, HER3, EGFR, HER2, Cetuximab, ERBITUX, Bispecific, Monoclonal Antibody, AIMM, AI Molecular Medicine, Rational Antibody Discovery, AIRE,

SINGAPORE — September 30, 2026 Hummingbird Bioscience announced that the first patient has been dosed in the Phase II...